Could universal opt-out HIV testing in Italian emergency departments be a cost-effective way of increasing HIV diagnosis rates in Italy?
In Italy, 60% of new HIV diagnoses are in people who already have advanced disease (i.e., a CD4 count <350 cells/mm3) (1). This highlights an urgent need for alternative screening strategies if Italy is to make progress towards achieving the UNAIDS target of diagnosing at least 95% of people living with HIV (2). Read More >
How can economic models inform decision-making about screening programmes?
Dr Elisabeth Adams, Managing Director and Founder of Aquarius Population Health, spoke at a continuing medical education webinar for health professionals hosted on September 23,2020 by the Consortium for Infectious Disease Control (CIDC). With increasing demands on time and resources, decision-makers in healthcare need information about how to create a safe, effective and cost-effective Read More >
Using an mRNA versus DNA test in the English cervical screening programme can save £15m annually and reduce unnecessary testing
The results of our economic evaluation comparing the use of mRNA and DNA assays in screening for cervical cancer in England were published in BMJ Open and are now available online. Results show large cost savings from avoiding unnecessary testing and follow-up, which can benefit women and healthcare services. Read More >